OSA
Stories
-
Apnimed posts results of Phase 3 AD109 trial in obstructive sleep apnea
The study, enrolling 660 participants, compared AD109 to placebo over 1 year and was completed with primary data posted on November 3, 2026. It began on August 28, 2023 and reached primary completion on May 7, 2025.